Ayurvedic management of amavata (Rheumatoid arthritis)

Completed

• Conditions: amavata (rheumatoid arthritis)

• Registration Number: CTRI/2016/11/007510
• Lead Sponsor: J S ayurveda college

Brief Summary

Clinical evaluation of the effectiveness of vardhaman pippali kalpa in the management of amavata is the main object of the study. Patients will be selected from the P D Patel ayurveda hospital, Nadiad, after the confirmation of the diagnosis of amavata with the help of classical signs and symptoms. they will be treated with Powder of pippali (*Piper longum* Linn.) in vardhmana krama,i.e. starting the dose from 1 gm on the first day, twice a day with hot water will given. It will be increased by 1 gm daily up to a maximum dose of 5 gm twice a day. The maximum dose, i.e.5 gm will be given for 5 days and then it will be tapered by 1 gm daily to a dose of 1 gm twice a day. Patients will be kept on mudgayuá¹£a. Total duration of the treatment will be of 13 days. Assessment will be done with the help of changes in gradation of the signs and symptoms of amavata, ESR, DAS-28 scale, disability  index (the indian health assessment questionnaire). Result will be analysed with student t test.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-01
• Study Completion: 2017-12-16
• Last Update Posted: 2018-03-22

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1.Presence of sandhiÅ›ula (pain in joints), sandhijÄdyatÄ (stiffness in joints), sandhisotha (swelling in joints), restriction of movement.
• 2.Presence of any six out of the following ten classification criteria and European league against rheumatism (EULAR).

Exclusion Criteria

• 1.Patients who have developed complications of rheumatoid arthritis e.g. Severe deformity of jointsones, pleura-pericardial disease, or else.
• 2.Association of a joint disease of other origin.
• 3.Patients having HbA1c above 7.5 of diabetes mellitus.
• 4.Patients on prolonged medication with immunosuppressive e.g. corticosteroids any other drugs within last 6 months that may have an influence on the outcome of the study.
• 5.Pregnant/lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
effect of the vardhamana pippali kalpa in the patients of amavata	Grade score of signs and symptoms

Trial Locations

Locations (1)

P D Patel Ayurveda Hospital; 🇮🇳 Kheda, GUJARAT, India

P D Patel Ayurveda Hospital

🇮🇳Kheda, GUJARAT, India

Manisha T Parmar

Principal investigator

9714754287

dr.manishaparmar41@gmail.com